BlackRock’s Edesa Biotech EDSA Stock Holding History

BlackRock’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224K	Sell	27,495 -214	-0.8%	-$1.93K	﹤0.01%	4784
2026 Q1	$145K	Buy	+27,709	New	+$83.1K	﹤0.01%	4872
2024 Q1	–	Sell	-74	Closed	-$338	–	5305
2023 Q4	$338	Hold	74	–	–	﹤0.01%	5302
2023 Q3	$327	Hold	74	–	–	﹤0.01%	5368
2023 Q2	$420	Hold	74	–	–	﹤0.01%	5431
2023 Q1	$472	Hold	74	–	–	﹤0.01%	5488
2022 Q4	$1.12K	Hold	74	–	–	﹤0.01%	5631
2022 Q3	$0	Hold	74	–	–	﹤0.01%	5825
2022 Q2	$1K	Hold	74	–	–	﹤0.01%	5776
2022 Q1	$2K	Hold	74	–	–	﹤0.01%	5738
2021 Q4	$3K	Buy	+74	New	+$3.54K	﹤0.01%	5674

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock's EDSA Position: Q2 2026 in Review

BlackRock reduced its Edesa Biotech (EDSA) stake by 0.77% in Q2 2026, selling an estimated $1.93K and leaving 27,495 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #4784.

BlackRock first reported a position in EDSA in Q4 2021 and has held it in 11 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

BlackRock held 27,495 shares of Edesa Biotech worth $224K as of Q2 2026.
BlackRock sold 214 Edesa Biotech shares in Q2 2026, an estimated $1.93K.
Edesa Biotech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4784 holding.
BlackRock first reported a position in Edesa Biotech in Q4 2021 and has held it in 11 quarters since.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.